跳转到内容

甲状腺激素β受体

本页使用了标题或全文手工转换
维基百科,自由的百科全书
甲状腺激素β受体
已知的結構
PDB直系同源搜索: PDBe RCSB
識別號
别名THRB;, C-ERBA-2, C-ERBA-BETA, ERBA2, GRTH, NR1A2, PRTH, THR1, THRB1, THRB2, thyroid hormone receptor beta, TRbeta
外部IDOMIM190160 MGI98743 HomoloGene36025 GeneCardsTHRB
相關疾病
selective pituitary resistance to thyroid hormone、​generalized resistance to thyroid hormone[1]
為以下藥物的標靶
反三碘甲状腺原氨酸、​替拉曲可、​三碘甲腺原氨酸、​左旋甲狀腺素鈉[2]
基因位置(人类
3號染色體
染色体3號染色體[3]
3號染色體
甲状腺激素β受体的基因位置
甲状腺激素β受体的基因位置
基因座3p24.2起始24,117,153 bp[3]
终止24,495,756 bp[3]
RNA表达模式
查阅更多表达数据
直系同源
物種人類小鼠
Entrez
Ensembl
UniProt
mRNA​序列

NM_001113417
​NM_009380

蛋白序列

NP_001106888
​NP_033406

基因位置​(UCSC)Chr 3: 24.12 – 24.5 MbChr 14: 4.43 – 4.81 Mb
PubMed​查找[5][6]
維基數據
檢視/編輯人類檢視/編輯小鼠

甲状腺激素β受体(TR-β,或THR-β)也称为核受体亚家族1,A 组,成员2(NR1A2),是一种核受体蛋白,在人类中由THR-β基因编码。[7][8]

功能

[编辑]

该基因编码的蛋白质为三碘甲腺原氨酸的核激素受体。它是甲状腺激素的多种受体之一,已被证明可以调节甲状腺激素的生物活性。小鼠基因敲除研究表明,不同的受体虽然具有一定程度的冗余,但可能介导甲状腺激素的不同功能。已知该基因的缺陷是导致:广泛性 甲状腺激素抵抗(GTHR)的成因。该综合征疾病的特征为:甲状腺肿大;循环甲状腺激素(T3-T4)水平增加;同时促甲状腺激素(TSH)正常或略微升高。现已发现到该基因的几种转录变体,但迄今为止只观察到一种的全长天然基因。[9]

基因互作

[编辑]

甲状腺激素β受体已被证明与以下存在基因相互作用

参考文献

[编辑]
  1. ^ 與甲状腺激素β受体相關的疾病;在維基數據上查看/編輯參考. 
  2. ^ 對Thyroid hormone receptor beta起作用的藥物;在維基數據上查看/編輯參考. 
  3. ^ 3.0 3.1 3.2 GRCh38: Ensembl release 89: ENSG00000151090 - Ensembl, May 2017
  4. ^ 4.0 4.1 4.2 GRCm38: Ensembl release 89: ENSMUSG00000021779 - Ensembl, May 2017
  5. ^ Human PubMed Reference:. National Center for Biotechnology Information, U.S. National Library of Medicine. 
  6. ^ Mouse PubMed Reference:. National Center for Biotechnology Information, U.S. National Library of Medicine. 
  7. ^ Entrez Gene: THRA thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian). 
  8. ^ Sakurai A, Nakai A, DeGroot LJ. Structural analysis of human thyroid hormone receptor beta gene. Mol. Cell. Endocrinol. June 1990, 71 (2): 83–91. PMID 1973914. S2CID 54389426. doi:10.1016/0303-7207(90)90245-4. 
  9. ^ Entrez Gene: THRB thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian). 
  10. ^ 10.0 10.1 Monden T, Wondisford FE, Hollenberg AN. Isolation and characterization of a novel ligand-dependent thyroid hormone receptor-coactivating protein. J. Biol. Chem. November 1997, 272 (47): 29834–41. PMID 9368056. doi:10.1074/jbc.272.47.29834可免费查阅. 
  11. ^ Lin HM, Zhao L, Cheng SY. Cyclin D1 Is a Ligand-independent Co-repressor for Thyroid Hormone Receptors. J. Biol. Chem. August 2002, 277 (32): 28733–41. PMID 12048199. doi:10.1074/jbc.M203380200可免费查阅. 
  12. ^ 12.0 12.1 Liu Y, Takeshita A, Misiti S, Chin WW, Yen PM. Lack of coactivator interaction can be a mechanism for dominant negative activity by mutant thyroid hormone receptors. Endocrinology. October 1998, 139 (10): 4197–204. PMID 9751500. doi:10.1210/endo.139.10.6218可免费查阅. 
  13. ^ 13.0 13.1 Jeyakumar M, Tanen MR, Bagchi MK. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor. Mol. Endocrinol. June 1997, 11 (6): 755–67. PMID 9171239. doi:10.1210/mend.11.6.0003可免费查阅. 
  14. ^ Lee SK, Jung SY, Kim YS, Na SY, Lee YC, Lee JW. Two distinct nuclear receptor-interaction domains and CREB-binding protein-dependent transactivation function of activating signal cointegrator-2. Mol. Endocrinol. February 2001, 15 (2): 241–54. PMID 11158331. doi:10.1210/mend.15.2.0595可免费查阅. 
  15. ^ Lee SK, Anzick SL, Choi JE, Bubendorf L, Guan XY, Jung YK, Kallioniemi OP, Kononen J, Trent JM, Azorsa D, Jhun BH, Cheong JH, Lee YC, Meltzer PS, Lee JW. A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo. J. Biol. Chem. November 1999, 274 (48): 34283–93. PMID 10567404. doi:10.1074/jbc.274.48.34283可免费查阅. 
  16. ^ Ko L, Cardona GR, Chin WW. Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator. Proc. Natl. Acad. Sci. U.S.A. May 2000, 97 (11): 6212–7. Bibcode:2000PNAS...97.6212K. PMC 18584可免费查阅. PMID 10823961. doi:10.1073/pnas.97.11.6212可免费查阅. 
  17. ^ Ko L, Cardona GR, Iwasaki T, Bramlett KS, Burris TP, Chin WW. Ser-884 adjacent to the LXXLL motif of coactivator TRBP defines selectivity for ERs and TRs. Mol. Endocrinol. January 2002, 16 (1): 128–40. PMID 11773444. doi:10.1210/mend.16.1.0755可免费查阅. 
  18. ^ Tagami T, Lutz WH, Kumar R, Jameson JL. The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators. Biochem. Biophys. Res. Commun. December 1998, 253 (2): 358–63. PMID 9878542. doi:10.1006/bbrc.1998.9799. 
  19. ^ Ando S, Sarlis NJ, Krishnan J, Feng X, Refetoff S, Zhang MQ, Oldfield EH, Yen PM. Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance. Mol. Endocrinol. September 2001, 15 (9): 1529–38. PMID 11518802. doi:10.1210/mend.15.9.0687可免费查阅. 
  20. ^ Zhu XG, Park KS, Kaneshige M, Bhat MK, Zhu Q, Mariash CN, McPhie P, Cheng SY. The orphan nuclear receptor Ear-2 is a negative coregulator for thyroid hormone nuclear receptor function. Mol. Cell. Biol. April 2000, 20 (7): 2604–18. PMC 85476可免费查阅. PMID 10713182. doi:10.1128/MCB.20.7.2604-2618.2000. 
  21. ^ Wu Y, Delerive P, Chin WW, Burris TP. Requirement of helix 1 and the AF-2 domain of the thyroid hormone receptor for coactivation by PGC-1. J. Biol. Chem. March 2002, 277 (11): 8898–905. PMID 11751919. doi:10.1074/jbc.M110761200可免费查阅. 

扩展阅读

[编辑]


甲状腺激素β受体引用了美国国家医学图书馆提供的資料,这些資料属于公共领域

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy